Baltimore Liquid Biopsy Startup Haystack Oncology Raises $56M in Series A Round

The Johns Hopkins University researchers behind two of Baltimore's most successful biotech firms have founded a new company that has now raised $56 million to create a new diagnostic tool for cancer.